ArticleDrug design, development and therapy2022

Astragaloside IV Alleviates Renal Tubular Epithelial-Mesenchymal Transition via CX3CL1-RAF/MEK/ERK Signaling Pathway in Diabetic Kidney Disease.

Yonghui Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.